Physician profile
Jule Wellner
NPI 1740812783
$2,415.63
in general payments reported to CMS, 2019-2025
24 companies · $531 in 2025
The $531 reported for 2025 was more than what 87% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $779 · 2022: $246 · 2023: $462 · 2024: $398 · 2025: $531.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,292 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,291.76 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $504.72 | 2021-2025 | |
| Exeltis, USA INC. | $428.75 | 2021-2025 | Slynd |
| Sumitomo Pharma America, INC. | $280.85 | 2023-2025 | Myfembree, Gemtesa |
| Astellas Pharma US INC | $246.22 | 2023-2025 | Veozah |
| Mylan Pharmaceuticals INC. | $161.47 | 2021-2022 | |
| Abbvie INC. | $115.90 | 2021-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $90.52 | 2021-2025 | |
| Myovant Sciences INC. | $85.23 | 2021-2022 | |
| Novo Nordisk INC | $64.32 | 2021-2023 | Wegovy |
| Agile Therapeutics, INC. | $62.43 | 2021 | |
| Abbott Laboratories | $54.92 | 2023-2024 | Freestyle Libre 3 |
| Lilly USA, LLC | $42.94 | 2021 | |
| Hologic Sales and Service, LLC | $41.72 | 2021-2024 | Myosure Tissue Removal Device, Novasure, Fluent Fluid Management System |
| Organon LLC | $40.34 | 2023-2025 | Nexplanon, Jada System |
| Sage Therapeutics, LLC | $32.59 | 2023-2024 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $31.07 | 2022 | |
| Millicent US INC | $22.41 | 2025 | Femlyv |
| Sanofi Pasteur INC. | $17.99 | 2024 | |
| Daiichi Sankyo INC. | $17.46 | 2023 | Injectafer |
| Exact Sciences Corporation | $17.06 | 2025 | Cologuard Collection Kit |
| Vertex Pharmaceuticals Incorporated | $16.26 | 2024 | |
| Lupin INC. | $15.47 | 2021 | |
| Vbi Vaccine (Delaware) INC. | $13.91 | 2022 | |
| Merck Sharp & Dohme LLC | $11.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jule Wellner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.